Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines

A large body of data both in animals and humans demonstrates that the gut microbiome plays a fundamental role in cancer immunity and in determining the efficacy of cancer immunotherapy. In this work, we have investigated whether and to what extent the gut microbiome can influence the antitumor activ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michele Tomasi, Mattia Dalsass, Francesco Beghini, Ilaria Zanella, Elena Caproni, Laura Fantappiè, Assunta Gagliardi, Carmela Irene, Enrico König, Luca Frattini, Giulia Masetti, Samine Jessica Isaac, Federica Armanini, Fabio Cumbo, Aitor Blanco-Míguez, Alberto Grandi, Nicola Segata, Guido Grandi
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/123201bff12b4c2b9b6af5be9639b822
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:123201bff12b4c2b9b6af5be9639b822
record_format dspace
spelling oai:doaj.org-article:123201bff12b4c2b9b6af5be9639b8222021-11-25T19:11:35ZCommensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines10.3390/vaccines91113562076-393Xhttps://doaj.org/article/123201bff12b4c2b9b6af5be9639b8222021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1356https://doaj.org/toc/2076-393XA large body of data both in animals and humans demonstrates that the gut microbiome plays a fundamental role in cancer immunity and in determining the efficacy of cancer immunotherapy. In this work, we have investigated whether and to what extent the gut microbiome can influence the antitumor activity of neo-epitope-based cancer vaccines in a BALB/c-CT26 cancer mouse model. Similarly to that observed in the C57BL/6-B16 model, <i>Bifidobacterium</i> administration per se has a beneficial effect on CT26 tumor inhibition. Furthermore, the combination of <i>Bifidobacterium</i> administration and vaccination resulted in a protection which was superior to vaccination alone and to <i>Bifidobacterium</i> administration alone, and correlated with an increase in the frequency of vaccine-specific T cells. The gut microbiome analysis by 16S rRNA gene sequencing and shotgun metagenomics showed that tumor challenge rapidly altered the microbiome population, with <i>Muribaculaceae</i> being enriched and <i>Lachnospiraceae</i> being reduced. Over time, the population of <i>Muribaculaceae</i> progressively reduced while the <i>Lachnospiraceae</i> population increased—a trend that appeared to be retarded by the oral administration of <i>Bifidobacterium</i>. Interestingly, in some <i>Bacteroidales</i>, <i>Prevotella</i> and <i>Muribaculacee</i> species we identified sequences highly homologous to immunogenic neo-epitopes of CT26 cells, supporting the possible role of “molecular mimicry” in anticancer immunity. Our data strengthen the importance of the microbiome in cancer immunity and suggests a microbiome-based strategy to potentiate neo-epitope-based cancer vaccines.Michele TomasiMattia DalsassFrancesco BeghiniIlaria ZanellaElena CaproniLaura FantappièAssunta GagliardiCarmela IreneEnrico KönigLuca FrattiniGiulia MasettiSamine Jessica IsaacFederica ArmaniniFabio CumboAitor Blanco-MíguezAlberto GrandiNicola SegataGuido GrandiMDPI AGarticlecancer vaccinesmicrobiomeimmunotherapyOMVspersonalized medicineMedicineRENVaccines, Vol 9, Iss 1356, p 1356 (2021)
institution DOAJ
collection DOAJ
language EN
topic cancer vaccines
microbiome
immunotherapy
OMVs
personalized medicine
Medicine
R
spellingShingle cancer vaccines
microbiome
immunotherapy
OMVs
personalized medicine
Medicine
R
Michele Tomasi
Mattia Dalsass
Francesco Beghini
Ilaria Zanella
Elena Caproni
Laura Fantappiè
Assunta Gagliardi
Carmela Irene
Enrico König
Luca Frattini
Giulia Masetti
Samine Jessica Isaac
Federica Armanini
Fabio Cumbo
Aitor Blanco-Míguez
Alberto Grandi
Nicola Segata
Guido Grandi
Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
description A large body of data both in animals and humans demonstrates that the gut microbiome plays a fundamental role in cancer immunity and in determining the efficacy of cancer immunotherapy. In this work, we have investigated whether and to what extent the gut microbiome can influence the antitumor activity of neo-epitope-based cancer vaccines in a BALB/c-CT26 cancer mouse model. Similarly to that observed in the C57BL/6-B16 model, <i>Bifidobacterium</i> administration per se has a beneficial effect on CT26 tumor inhibition. Furthermore, the combination of <i>Bifidobacterium</i> administration and vaccination resulted in a protection which was superior to vaccination alone and to <i>Bifidobacterium</i> administration alone, and correlated with an increase in the frequency of vaccine-specific T cells. The gut microbiome analysis by 16S rRNA gene sequencing and shotgun metagenomics showed that tumor challenge rapidly altered the microbiome population, with <i>Muribaculaceae</i> being enriched and <i>Lachnospiraceae</i> being reduced. Over time, the population of <i>Muribaculaceae</i> progressively reduced while the <i>Lachnospiraceae</i> population increased—a trend that appeared to be retarded by the oral administration of <i>Bifidobacterium</i>. Interestingly, in some <i>Bacteroidales</i>, <i>Prevotella</i> and <i>Muribaculacee</i> species we identified sequences highly homologous to immunogenic neo-epitopes of CT26 cells, supporting the possible role of “molecular mimicry” in anticancer immunity. Our data strengthen the importance of the microbiome in cancer immunity and suggests a microbiome-based strategy to potentiate neo-epitope-based cancer vaccines.
format article
author Michele Tomasi
Mattia Dalsass
Francesco Beghini
Ilaria Zanella
Elena Caproni
Laura Fantappiè
Assunta Gagliardi
Carmela Irene
Enrico König
Luca Frattini
Giulia Masetti
Samine Jessica Isaac
Federica Armanini
Fabio Cumbo
Aitor Blanco-Míguez
Alberto Grandi
Nicola Segata
Guido Grandi
author_facet Michele Tomasi
Mattia Dalsass
Francesco Beghini
Ilaria Zanella
Elena Caproni
Laura Fantappiè
Assunta Gagliardi
Carmela Irene
Enrico König
Luca Frattini
Giulia Masetti
Samine Jessica Isaac
Federica Armanini
Fabio Cumbo
Aitor Blanco-Míguez
Alberto Grandi
Nicola Segata
Guido Grandi
author_sort Michele Tomasi
title Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
title_short Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
title_full Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
title_fullStr Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
title_full_unstemmed Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
title_sort commensal <i>bifidobacterium</i> strains enhance the efficacy of neo-epitope based cancer vaccines
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/123201bff12b4c2b9b6af5be9639b822
work_keys_str_mv AT micheletomasi commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT mattiadalsass commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT francescobeghini commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT ilariazanella commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT elenacaproni commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT laurafantappie commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT assuntagagliardi commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT carmelairene commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT enricokonig commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT lucafrattini commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT giuliamasetti commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT saminejessicaisaac commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT federicaarmanini commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT fabiocumbo commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT aitorblancomiguez commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT albertograndi commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT nicolasegata commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
AT guidograndi commensalibifidobacteriumistrainsenhancetheefficacyofneoepitopebasedcancervaccines
_version_ 1718410137665798144